rs199586268
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6BS1BS2_Supporting
The ENST00000393562.10(G6PD):c.1288-10_1288-9del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0016 in 1,209,692 control chromosomes in the GnomAD database, including 23 homozygotes. There are 514 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0085 ( 13 hom., 261 hem., cov: 24)
Exomes 𝑓: 0.00090 ( 10 hom. 253 hem. )
Consequence
G6PD
ENST00000393562.10 splice_polypyrimidine_tract, intron
ENST00000393562.10 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.707
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant X-154532470-GGA-G is Benign according to our data. Variant chrX-154532470-GGA-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 193829.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=2, Likely_benign=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0085 (957/112639) while in subpopulation AFR AF= 0.0286 (888/31063). AF 95% confidence interval is 0.027. There are 13 homozygotes in gnomad4. There are 261 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 XL geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.1288-10_1288-9del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000393562.10 | NP_001346945.1 | |||
G6PD | NM_000402.4 | c.1378-10_1378-9del | splice_polypyrimidine_tract_variant, intron_variant | NP_000393.4 | ||||
G6PD | NM_001042351.3 | c.1288-10_1288-9del | splice_polypyrimidine_tract_variant, intron_variant | NP_001035810.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.1288-10_1288-9del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001360016.2 | ENSP00000377192 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00848 AC: 955AN: 112589Hom.: 13 Cov.: 24 AF XY: 0.00751 AC XY: 261AN XY: 34739
GnomAD3 genomes
AF:
AC:
955
AN:
112589
Hom.:
Cov.:
24
AF XY:
AC XY:
261
AN XY:
34739
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00237 AC: 432AN: 182556Hom.: 4 AF XY: 0.00162 AC XY: 109AN XY: 67266
GnomAD3 exomes
AF:
AC:
432
AN:
182556
Hom.:
AF XY:
AC XY:
109
AN XY:
67266
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000896 AC: 983AN: 1097053Hom.: 10 AF XY: 0.000698 AC XY: 253AN XY: 362519
GnomAD4 exome
AF:
AC:
983
AN:
1097053
Hom.:
AF XY:
AC XY:
253
AN XY:
362519
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00850 AC: 957AN: 112639Hom.: 13 Cov.: 24 AF XY: 0.00750 AC XY: 261AN XY: 34799
GnomAD4 genome
AF:
AC:
957
AN:
112639
Hom.:
Cov.:
24
AF XY:
AC XY:
261
AN XY:
34799
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 14, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 27, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Sep 21, 2021 | - - |
G6PD deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
G6PD-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at